VIATRIS INC (VTRS) Stock Price, Quote, News and Overview
NASDAQ:VTRS - Nasdaq - US92556V1061 - Common Stock - Currency: USD
VTRS Quote, Performance and Key Statistics
8.77
-0.32 (-3.52%)
The current stock price of VTRS is 8.77 USD. In the past month the price increased by 20.8%. In the past year, price decreased by -21.42%.
VTRS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 53.38 | 696.37B | ||
| JNJ | JOHNSON & JOHNSON | 15.35 | 371.06B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 18.9 | 291.96B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.08 | 214.69B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.16 | 209.49B | ||
| MRK | MERCK & CO. INC. | 9.75 | 191.17B | ||
| PFE | PFIZER INC | 6.94 | 126.36B | ||
| SNY | SANOFI-ADR | 13.1 | 122.16B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.33 | 94.53B | ||
| GSK | GSK PLC-SPON ADR | 6.72 | 74.10B | ||
| ZTS | ZOETIS INC | 26.46 | 71.04B | ||
| HLN | HALEON PLC-ADR | 22.38 | 48.43B |
Related stock screener links
About VTRS
Company Profile
Viatris, Inc. is a global healthcare company, which engages in the provision of healthcare and pharmaceutical products. The company is headquartered in Canonsburg, Pennsylvania and currently employs 32,000 full-time employees. The firm's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s Antiretroviral medicines (ARV) franchise. Its pipeline and research and development capabilities include expertise in formulation, device development, toxicology, analytical, clinical, bioanalytical, medical affairs, product safety and risk management across a range of therapeutic areas. The company produces oral solid doses, injectables, and products with complex dosage forms.
Company Info
VIATRIS INC
1000 Mylan Boulevard
Canonsburg PENNSYLVANIA 15317 US
CEO: Michael Goettler
Employees: 33000
Phone: 17245141465
VIATRIS INC / VTRS FAQ
What is the stock price of VIATRIS INC today?
The current stock price of VTRS is 8.77 USD. The price decreased by -3.52% in the last trading session.
What is the ticker symbol for VIATRIS INC stock?
The exchange symbol of VIATRIS INC is VTRS and it is listed on the Nasdaq exchange.
On which exchange is VTRS stock listed?
VTRS stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for VIATRIS INC stock?
15 analysts have analysed VTRS and the average price target is 11.27 USD. This implies a price increase of 28.47% is expected in the next year compared to the current price of 8.77. Check the VIATRIS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is VIATRIS INC worth?
VIATRIS INC (VTRS) has a market capitalization of 10.47B USD. This makes VTRS a Large Cap stock.
How many employees does VIATRIS INC have?
VIATRIS INC (VTRS) currently has 33000 employees.
What are the support and resistance levels for VIATRIS INC (VTRS) stock?
VIATRIS INC (VTRS) has a support level at 8.57 and a resistance level at 8.78. Check the full technical report for a detailed analysis of VTRS support and resistance levels.
Is VIATRIS INC (VTRS) expected to grow?
The Revenue of VIATRIS INC (VTRS) is expected to decline by -6.8% in the next year. Check the estimates tab for more information on the VTRS EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy VIATRIS INC (VTRS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of VTRS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of VTRS, evaluating the profitability, health, valuation and growth aspects
- VIATRIS INC (VTRS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- VIATRIS INC (VTRS) Sales and EPS estimates to see what analysts future expectations are.
- VIATRIS INC (VTRS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- VIATRIS INC (VTRS) Insider and Institutional Ownership to learn about the owners and their transactions.
- VIATRIS INC (VTRS) Stock Chart to make your own analysis
- VIATRIS INC (VTRS) Latest news and press-releases to stay up to date.
Does VIATRIS INC (VTRS) stock pay dividends?
VIATRIS INC (VTRS) has a dividend yield of 5.47%. The yearly dividend amount is currently 0.48. Check the full fundamental report for a detailed analysis of VTRS dividend history, reliability and sustainability.
When does VIATRIS INC (VTRS) report earnings?
VIATRIS INC (VTRS) will report earnings on 2025-08-06, before the market open.
What is the Price/Earnings (PE) ratio of VIATRIS INC (VTRS)?
The PE ratio for VIATRIS INC (VTRS) is 3.54. This is based on the reported non-GAAP earnings per share of 2.48 and the current share price of 8.77 USD. Check the full fundamental report for a full analysis of the valuation metrics for VTRS.
What is the Short Interest ratio of VIATRIS INC (VTRS) stock?
The outstanding short interest for VIATRIS INC (VTRS) is 3.87% of its float. Check the ownership tab for more information on the VTRS short interest.
VTRS Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to VTRS. When comparing the yearly performance of all stocks, VTRS is a bad performer in the overall market: 78.84% of all stocks are doing better.
VTRS Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to VTRS. While VTRS is still in line with the averages on profitability rating, there are concerns on its financial health.
VTRS Financial Highlights
Over the last trailing twelve months VTRS reported a non-GAAP Earnings per Share(EPS) of 2.48. The EPS decreased by -12.37% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1.53% | ||
| ROE | -3.4% | ||
| Debt/Equity | 0.75 |
VTRS Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 72% to VTRS. The Buy consensus is the average rating of analysts ratings from 15 analysts.
For the next year, analysts expect an EPS growth of -15.15% and a revenue growth -6.8% for VTRS